Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEUS Trial: Zastaprazan for Preventing Upper GI Bleeding in TIA/Stroke Patients on Antiplatelet/Anticoagulant Therapy
NCT07730840Phase 3Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Oct 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in upper gastrointestinal bleeding (UGIB), sponsored by Asan Medical Center. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
zastaprazan
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT07730840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730840.